Company / Depreciation & Amortization
ACCENDRA HEALTH INC/VA/ Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$214.5M
FY2025
5-year range
$116.7M / $228.7M
FY2021-FY2025
Trend
+18.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Depreciation & Amortization returned to growth in FY2025 after 2 years of decline, reaching $215M.
Based on SEC 10-K filings.
$215M in FY2025 with a 5-year CAGR of +18.1%.
Remained stable around $215M over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -2.1%
- 5-Year CAGR
- +18.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +18.1%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 18.3% year-over-year.
- Peak depreciation & amortization was recorded in FY2022.
- Lowest depreciation & amortization in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.60 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $214.5M | +18.3% |
| FY2024 | $181.3M | -13.8% |
| FY2023 | $210.4M | -8.0% |
| FY2022 | $228.7M | +96.0% |
| FY2021 | $116.7M | +25.0% |
| FY2020 | $93.3M | -8.4% |
| FY2019 | $101.9M | +0.0% |
| FY2018 | $101.9M | +71.5% |
| FY2017 | $59.4M | +7.3% |
| FY2016 | $55.4M | -16.0% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026